Clinical Trials Insight: 700051064

Trial Profile

Clinical Trials Insight: 700051064

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 17 Nov 2009

At a glance

  • Drugs ARG 301 (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Sponsors arGentis Pharmaceuticals
  • Most Recent Events

    • 17 Nov 2009 New trial record.
    • 13 Nov 2009 arGentis Pharmaceuticals will collaberate with the University of Tennessee Health Science Center and the Veterans Affairs Medical Center of Mephis to initiate this trial, according to a arGentis Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top